Skip to main content
. 2004 Jun;72(6):3451–3460. doi: 10.1128/IAI.72.6.3451-3460.2004

FIG. 6.

FIG. 6.

Inhibition of binding by MAbs with different specificities. The average of duplicates for a 1/20 dilution of PBS immune serum, Vac1 immune serum, Vac2 immune serum, and Vac3 immune serum are shown. The blocking MAbs were added at 100 μg/ml, or buffer was added as a control. (A) OAc+-specific MAb 2055.5. (B) OAc ≫ OAc+-specific MAb 2016.3. (C) OAc+ ≈ OAc >>> K92-specific MAb C2/1076.10.